In short

J0713 is the HCPCS Level II code for injection, ceftazidime, per 500 mg. CMS assigns NDCs for Ceftazidime and Tazicef to it. One billing unit is 500 mg. The Medicare Part B payment limit is $1.549 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file
HCPCS codeJ0713
Billing unit500 mg
Descriptor
Injection, ceftazidime, per 500 mg
Short descriptor
Inj ceftazidime per 500 mg
Code set
HCPCS Level II, maintained by CMS
Effective
Jan 1, 1997

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file
Payment limit per unit$1.549
Per500 mg
Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 500 mg. For example, 50000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Enter the dose given to build the claim line.

NDCs billed under J0713

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 15 NDCs to J0713 for Ceftazidime and Tazicef. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J0713 in the CMS ASP crosswalk
DrugNDC (11-digit)LabelerPackageBilling units per package
Ceftazidime25021-0127-20Sagent Pharmaceuticals25 × 150
Ceftazidime25021-0127-66Sagent Pharmaceuticals25 × 150
Ceftazidime25021-0128-50Sagent Pharmaceuticals10 × 140
Ceftazidime25021-0128-67Sagent Pharmaceuticals10 × 140
Ceftazidime25021-0129-69Sagent Pharmaceuticals6 × 172
Ceftazidime25021-0129-99Sagent Pharmaceuticals6 × 172
Ceftazidime44567-0235-25WG Critical Care, LLC25 × 150
Ceftazidime44567-0236-10WG Critical Care, LLC10 × 140
Ceftazidime44567-0237-06WG Critical Care, LLC6 × 172
Tazicef00409-5082-10Pfizer Inc10 × 120
Tazicef00409-5082-16Pfizer Inc25 × 150
Tazicef00409-5084-11Pfizer Inc10 × 140
Tazicef00409-5086-11Pfizer Inc10 × 1120
Tazicef00409-5092-16Pfizer Inc25 × 150
Tazicef00409-5093-11Pfizer Inc10 × 140

J0713: common questions

Is J0713 a CPT code?
No. J0713 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J0713?
CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 15 NDCs under J0713, for Ceftazidime and Tazicef. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J0713?
$1.549 per 500 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J0713?
One unit of J0713 is 500 mg, as stated in the code's descriptor. Units to report = dose given ÷ 500 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in